New Horizons in Hyperpolarized 13C MRI.
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Hyperpolarization techniques significantly enhance the sensitivity of magnetic resonance (MR) and thus present fascinating new directions for research and applications with in vivo MR imaging and spectroscopy (MRI/S). Hyperpolarized 13C MRI/S, in particular, enables real-time non-invasive assessment of metabolic processes and holds great promise for a diverse range of clinical applications spanning fields like oncology, neurology, and cardiology, with a potential for improving early diagnosis of disease, patient stratification, and therapy response assessment. Despite its potential, technical challenges remain for achieving clinical translation. This paper provides an overview of the discussions that took place at the international workshop "New Horizons in Hyperpolarized 13C MRI," in March 2023 at the Bavarian Academy of Sciences and Humanities, Munich, Germany. The workshop covered new developments, as well as future directions, in topics including polarization techniques (particularly focusing on parahydrogen-based methods), novel probes, considerations related to data acquisition and analysis, and emerging clinical applications in oncology and other fields.
Description
Funder: Cancer Research UK Cambridge Institute, University of Cambridge; doi: http://dx.doi.org/10.13039/501100022011
Funder: NIHR Cambridge Biomedical Research Centre; doi: http://dx.doi.org/10.13039/501100018956
Funder: GlaxoSmithKline; doi: http://dx.doi.org/10.13039/100004330
Funder: AstraZeneca; doi: http://dx.doi.org/10.13039/100004325
Funder: GE Healthcare; doi: http://dx.doi.org/10.13039/100006775
Funder: Memorial Sloan-Kettering Cancer Center; doi: http://dx.doi.org/10.13039/100007052
Keywords
Journal Title
Conference Name
Journal ISSN
1860-2002
Volume Title
Publisher
Publisher DOI
Sponsorship
Cancer Research UK (C12912/A27150)
Cancer Research UK (EDDPMA-May22\100068)